Single-Dose Zilebesiran Cuts BP Out to 6 Months: KARDIA-2 Single-Dose Zilebesiran Cuts BP Out to 6 Months: KARDIA-2

This phase 2 study supports the potential for combining biannual dosing of zilebesiran with standard-of-care antihypertensives to achieve additive blood pressure reductions.Medscape Medical News

Source: Medscape Cardiology Headlines - April 15, 2024 Category: Cardiology Tags: Cardiology News Source Type: news